Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2000 1
2011 1
2016 1
2019 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Bladder Alveolar Rhabdomyosarcoma"
Page 1
Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
Buszek SM, Ludmir EB, Grosshans DR, McAleer MF, McGovern SL, Harrison DJ, Okcu MF, Chintagumpala MM, Mahajan A, Paulino AC. Buszek SM, et al. Pediatr Blood Cancer. 2019 Nov;66(11):e27952. doi: 10.1002/pbc.27952. Epub 2019 Aug 9. Pediatr Blood Cancer. 2019. PMID: 31397065
PURPOSE/OBJECTIVE(S): Bladder and prostate are unfavorable sites for rhabdomyosarcoma (B/P-RMS), and represent a challenging location for radiotherapy. ...Univariate analysis demonstrated an effect of tumor size on OS (tumor >5 cm, hazard ratio [HR] 17.7, P = .04 …
PURPOSE/OBJECTIVE(S): Bladder and prostate are unfavorable sites for rhabdomyosarcoma (B/P-RMS), and represent a challenging l …
Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
Buszek SM, Ludmir EB, Grosshans DR, McAleer MF, McGovern SL, Harrison DJ, Okcu MF, Chintagumpala MM, Mahajan A, Paulino AC. Buszek SM, et al. Int J Radiat Oncol Biol Phys. 2021 Mar 1;109(3):718-725. doi: 10.1016/j.ijrobp.2020.09.050. Int J Radiat Oncol Biol Phys. 2021. PMID: 33516439
Delayed RT delivery (13 weeks from initiation of CT) predicted worse LC (P = .01). Increased tumor size predicted both inferior PFS (P = .02) and OS (P = .01). ...Inferior LC, PFS, and OS rates were observed for patients with larger tumors and those treated w …
Delayed RT delivery (13 weeks from initiation of CT) predicted worse LC (P = .01). Increased tumor size predicted both inferio …
Durability of oncological outcomes of combination chemotherapy as a monotherapy for a select patient subset with non-metastatic non-alveolar bladder/prostate rhabdomyosarcoma.
Abdelhalim A, Atwa AM, Helmy TE, Dawaba ME, Elashry R, Hafez AT. Abdelhalim A, et al. J Pediatr Urol. 2021 Aug;17(4):535.e1-535.e8. doi: 10.1016/j.jpurol.2021.05.013. Epub 2021 May 17. J Pediatr Urol. 2021. PMID: 34092511
INTRODUCTION AND OBJECTIVES: We aim to assess the long-term oncological outcomes of children with bladder/prostate rhabdomyosarcoma (B/P RMS) treated with multiagent chemotherapy as a monotherapy. ...METHODS: Patients (21-year-old) treated for non-metastatic non- …
INTRODUCTION AND OBJECTIVES: We aim to assess the long-term oncological outcomes of children with bladder/prostate rhabdomyosarcom …
Patterns of Failure in Pediatric Rhabdomyosarcoma After Proton Therapy.
Vern-Gross TZ, Indelicato DJ, Bradley JA, Rotondo RL. Vern-Gross TZ, et al. Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1070-1077. doi: 10.1016/j.ijrobp.2016.08.028. Epub 2016 Aug 30. Int J Radiat Oncol Biol Phys. 2016. PMID: 27742542
PURPOSE: To report on the patterns of failure in children with rhabdomyosarcoma treated with proton therapy. PATIENTS AND METHODS: Between February 2007 and November 2013, 66 children with a median age of 4.1 years (range, 0.6-15.3 years) diagnosed with nonmetastatic rh …
PURPOSE: To report on the patterns of failure in children with rhabdomyosarcoma treated with proton therapy. PATIENTS AND METHODS: Be …
Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee.
Rodeberg DA, Anderson JR, Arndt CA, Ferrer FA, Raney RB, Jenney ME, Brecht IB, Koscielniak E, Carli M, Bisogno G, Oberlin O, Rey A, Ullrich F, Stevens MC, Meyer WH. Rodeberg DA, et al. Int J Cancer. 2011 Mar 1;128(5):1232-9. doi: 10.1002/ijc.25444. Int J Cancer. 2011. PMID: 20473932 Free article.
The purpose of this study was to determine patient characteristics and outcomes for bladder/prostate (BP) rhabdomyosarcoma (RMS) using an international cohort of prospectively treated patients comparing different treatment algorithms. ...Treatment failures were usua …
The purpose of this study was to determine patient characteristics and outcomes for bladder/prostate (BP) rhabdomyosarcoma (RM …
Primary mesenchymal tumors of the urinary bladder. A histological and immunohistochemical study of 30 cases.
Kunze E, Theuring F, Krüger G. Kunze E, et al. Pathol Res Pract. 1994 Apr;190(4):311-32. doi: 10.1016/S0344-0338(11)80404-8. Pathol Res Pract. 1994. PMID: 8078801 Review.
The light microscopic and immunohistochemical features of 30 primary mesenchymal neoplasms of the urinary bladder are reported. Half of the cases represented smooth and striated muscle tumors (five leiomyomas, seven leiomyosarcomas including epithelioid and myxoid s …
The light microscopic and immunohistochemical features of 30 primary mesenchymal neoplasms of the urinary bladder are reported …
Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study.
Bridge JA, Liu J, Weibolt V, Baker KS, Perry D, Kruger R, Qualman S, Barr F, Sorensen P, Triche T, Suijkerbuijk R. Bridge JA, et al. Genes Chromosomes Cancer. 2000 Apr;27(4):337-44. doi: 10.1002/(sici)1098-2264(200004)27:4<337::aid-gcc1>3.0.co;2-1. Genes Chromosomes Cancer. 2000. PMID: 10719362
In this investigation, 12 E-RMS specimens from 10 patients entered into Intergroup Rhabdomyosarcoma Study (IRS) I-IV and two local patients were analyzed by CGH and fluorescence in situ hybridization (FISH). ...Importantly, loss of 9q22 corresponds to the locus of a putati …
In this investigation, 12 E-RMS specimens from 10 patients entered into Intergroup Rhabdomyosarcoma Study (IRS) I-IV and two local pa …